Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 3/20 | 0.65 |
| ▸ | GPBAR1 | Q8TDU6 | 8/20 | 0.56 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.56 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.56 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.56 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.56 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.56 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.56 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.54 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.54 |
| ▸ | VDR | P11473 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6065533 | 0.93 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL58082 | 0.91 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL18045259 | 0.91 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL2285700 | 0.91 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL4777980 | 0.91 | EPHA2 (0.67) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Water SCHEMBL8333417 | 0.90 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Water SCHEMBL278724 | 0.90 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL5820770 | 0.89 | EPHA2 (0.66) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| Sulfuric Acid SCHEMBL5587293 | 0.89 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 | |
| SCHEMBL55596 | 0.89 | EPHA2 (0.68) | EPHA2GPBAR1AKR1B10AKR1B1EFNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150174209-A1 | INSULIN-PRAMLINTIDE COMPOSITIONS AND METHODS FOR MAKING AND USING THEM | AMYLIN PHARMACEUTICALS. LLC (US) | 2015-06-25 | — | — | US | claimed |
| WO-2013177565-A1 | INSULIN-PRAMLINTIDE COMPOSITIONS AND METHODS FOR MAKING AND USING THEM | AMYLIN PHARMACEUTICALS, LLC (US) | 2013-11-28 | — | — | WO | claimed |
| US-7312196-B2 | Formulations for amylin agonist peptides | AMYLIN PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | claimed |
| US-7160689-B2 | Pretreatment instrument of saliva and pretreatment method of saliva | GC CORPORATION (JP) | 2007-01-09 | — | — | US | claimed |
| EP-1396726-B1 | Pretreatment kit for saliva and pretreatment method for saliva for determination of Mutans streptococci via immunochromatography | G C DENTAL IND CORP (JP) | 2006-05-24 | — | — | EP | claimed |
| EP-1271124-B1 | Pretreatment instrument of saliva and pretreatment method of saliva | G C DENTAL IND CORP (JP) | 2006-03-22 | — | — | EP | claimed |
| US-6897037-B2 | Pre-treatment kit for saliva and pre-treatment method for saliva using the same | GC CORPORATION (JP) | 2005-05-24 | — | — | US | claimed |
| EP-1248106-B1 | Pre-treatment kit for saliva and pre-treatment method for saliva using the same | G C DENTAL IND CORP (JP) | 2004-06-02 | — | — | EP | claimed |
| US-20030203423-A1 | Pre-treatment kit for saliva and pre-treatment method for saliva using the same | GC CORPORATION (JP) | 2003-10-30 | — | — | US | claimed |
| EP-1271124-A1 | Pretreatment instrument of saliva and pretreatment method of saliva | GC Corporation (JP) | 2003-01-02 | — | — | EP | claimed |
| US-20020197738-A1 | Pretreatment instrument of saliva and pretreatment method of saliva | GC CORPORATION (JP) | 2002-12-26 | — | — | US | claimed |
| EP-1248106-A1 | Pre-treatment kit for saliva and pre-treatment method for saliva using the same | GC Corporation (JP) | 2002-10-09 | — | — | EP | claimed |
| US-20240192707-A1 | MICROFLUIDIC SYSTEM | THE UNIVERSITY OF CHICAGO | 2024-06-13 | — | — | US | disclosed |
| US-20240160231-A1 | MICROFLUIDIC SYSTEM | THE UNIVERSITY OF CHICAGO | 2024-05-16 | — | — | US | disclosed |
| US-11853087-B2 | Microfluidic system | THE UNIVERSITY OF CHICAGO (US) | 2023-12-26 | — | — | US | disclosed |
| EP-3290921-B1 | DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT AND REACTION | UNIV CHICAGO (US) | 2022-06-15 | — | — | EP | disclosed |
| EP-1248106-A1 | Pre-treatment kit for saliva and pre-treatment method for saliva using the same | GC Corporation (JP) | 2002-10-09 | — | — | EP | disclosed |
| US-20020137135-A1 | Novel NPG-1 gene that is differentially expressed in prostate tumors | BETH ISRAEL DEACONESS MEDICAL CENTER, INC., A MASSACHUSETTS CORPORATION | 2002-09-26 | — | — | US | disclosed |
| WO-2002057789-A2 | TEST FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES | ENFER TECHNOLOGY LIMITED (IE) | 2002-07-25 | — | — | WO | disclosed |
| US-6287777-B1 | SEVERAL GENES EXPRESSED DIFFERENTIALLY BETWEEN THE HUMAN PROSTATE CARCINOMA CELL LINES LNCAP AND PC-3, WHICH ARE ANDROGEN-DEPENDENT AND ANDROGEN-INDEPENDENT, RESPECTIVELY, HAVE NOW BEEN ISOLATED. ONE OF THESE GENES, DESIGNATED NPG-1. | BETH ISRAEL DEACONESS MEDICAL CENTER | 2001-09-11 | — | — | US | disclosed |